This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
6 - 8 June, 2023
Postillon Hotel AmsterdamDigital Experience: All Sessions Live-streamed 6-8 June, 2023

Dafne Muller, PhD
Group Leader at University of Stuttgart

Profile

Dafne Müller received her doctoral degree from the University of Stuttgart in Germany. At the present she holds a research group leader/lecturer position at the department of Biomedical Engineering at the Institute of Cell Biology and Immunology at the University of Stuttgart. Working in the field of recombinant antibodies for over 15 years, her current research focuses on the development of recombinant antibody-fusion proteins with immune stimulatory or costimulatory properties for targeted cancer immunotherapy.

Agenda Sessions

  • Trifunctional Immunocytokines for Cancer Therapy

    10:50

Speakers at this event